DBTX — Decibel Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
SVB Securities downgrades Decibel Therapeutics over cash concerns
U.S. STOCKS ON THE MOVE-Boxed, Roivant Sciences, U.S. banks
SVB Securities downgrades Decibel Therapeutics over cash concerns
Decibel Therapeutics Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: Decibel Therapeutics Reports Three Cash Deposit Accounts At Svb, Each With A Balance Less Than Or Equal To $250,000
Decibel rises on regulatory nod to begin hearing loss therapy trials in UK
Brief: Decibel Therapeutics Says U.K. MHRA Approves Clinical Trial Application For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Decibel Therapeutics Reports Third Quarter 2022 Financial Results
Decibel Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Decibel Therapeutics Submits Clinical Trial Applications For Lead Gene Therapy Candidate
U.S. STOCKS ON THE MOVE-Alvotech, Verizon, Lyft, BofA
U.S. STOCKS ON THE MOVE-Gold miners, Protera, Sorrento
Decibel Therapeutics gains on FDA nod for hearing loss therapy trial
Brief: Decibel Therapeutics Receives FDA Clearance Of Ind Application For Db-Oto, A Gene Therapy Product Candidate Designed To Provide Hearing To Individuals With Otoferlin-Related Hearing Loss
Brief: Decibel Therapeutics Appoints Kevin F. Mclaughlin To Its Board Of Directors
Brief: Decibel Therapeutics Submits IND Application For Phase 1/2 Clinical Trial In Pediatric Patients
Brief: Decibel Therapeutics Submits IND Application For Lead Gene Therapy Candidate
Brief: Decibel Therapeutics Inc Says Elisabeth Leiderman Notified Co Of Her Intent To Resign